V
Vigeo Therapeutics
0 followers
Vigeo is a clinical-stage biopharmaceutical company developing novel therapeutics that can effectively treat multiple types of cancer and improve the lives of patients.
Org chart
Jim Mahoney
CEO
Jim Mahoney
Collapse
Jing Watnick
COO
Judy Chiao
SVP, Clinical Development
Bill Craig
Head, CMC
Robert Clay
Head, Regulatory
Carl Weissman
Head, Business Development
Jenny Chen
Senior Director, Research & Development
Victor Zota
Director, Pathology Lab
Peter Finn
Corporate Counsel
Board & advisors
Stephanie Monaghan O’Brien
Director
Westley Nolin
Director